DEA schedule
Is abacavir and lamivudine a controlled substance?
Federal schedule for abacavir and lamivudine from the FDA NDC directory, checked against the DEA controlled substances list.
Source: FDA NDC Directory file dated 2026-10-22. Publisher page
No. Abacavir and lamivudine is not a federally controlled substance. None of its FDA NDC listings carries a DEA schedule, and abacavir and lamivudine is not on the DEA controlled substances list.
Run it in Rivvi
Which 2027 plans near you dropped or restricted abacavir and lamivudine?
Tier changes and new prior auth, step therapy or quantity limits, plan by plan.
Free to start. Opens Rivvi, the AI workspace for healthcare teams.
Schedule check
| Source | What it lists |
|---|---|
| FDA NDC directory | 6 prescription listings from 6 labelers, none with a DEA schedule |
| DEA controlled substances list | abacavir and lamivudine is not on the list |
Abacavir and Lamivudine NDC listings
| NDC | Product | Form | Strength | Labeler | DEA schedule |
|---|---|---|---|---|---|
| 31722-838 | ABACAVIR and LAMIVUDINE | tablet, film coated | 600 mg/1; 300 mg/1 | Camber Pharmaceuticals, Inc. | None |
| 33342-440 | Abacavir and Lamivudine | tablet, film coated | 600 mg/1; 300 mg/1 | Macleods Pharmaceuticals Limited | None |
| 42385-962 | Abacavir and Lamivudine | tablet, film coated | 600 mg/1; 300 mg/1 | Laurus Labs Limited | None |
| 65862-335 | Abacavir and Lamivudine | tablet, film coated | 600 mg/1; 300 mg/1 | Aurobindo Pharma Limited | None |
| 68180-288 | Abacavir and Lamivudine | tablet, film coated | 600 mg/1; 300 mg/1 | Lupin Pharmaceuticals, Inc. | None |
| 69097-362 | Abacavir and Lamivudine | tablet, film coated | 600 mg/1; 300 mg/1 | Cipla USA Inc. | None |
Questions
Is abacavir and lamivudine a controlled substance?
No. Abacavir and lamivudine is not a federally controlled substance. None of its FDA NDC listings carries a DEA schedule, and abacavir and lamivudine is not on the DEA controlled substances list.
Is abacavir and lamivudine a narcotic?
No. Abacavir and lamivudine is not on the DEA controlled substances list, so the DEA does not classify it as a narcotic. Its FDA established pharmacologic class is Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor and Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor.
Does this page cover state schedules?
No. This page reports the federal schedule only. Some states schedule drugs on their own; check your state board of pharmacy.
More on Abacavir and Lamivudine
- What is Abacavir and Lamivudine used for?FDA label uses
- Generic for EpzicomFDA Orange Book
- Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitors listFDA drug class
- Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitors listFDA drug class
- NDC 31722-838Abacavir and Lamivudine NDC record
- NDC 33342-440Abacavir and Lamivudine NDC record
- NDC 42385-962Abacavir and Lamivudine NDC record